These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 30671792

  • 21. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C, Duan D, Liu S.
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [Abstract] [Full Text] [Related]

  • 22. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
    Lv M, Wang K, Zhang Z, Zhang Z, Wan J.
    Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
    [Abstract] [Full Text] [Related]

  • 23. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
    Zhang JZ, Yang CX, Gao S, Bu JF, Li QQ, Wang HL, Yang KN, Tong SS, Qian LJ, Zhang J, Hua R, Sun YW, Yan JY, Chen W.
    World J Surg Oncol; 2023 Aug 05; 21(1):239. PubMed ID: 37542314
    [Abstract] [Full Text] [Related]

  • 24. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.
    Cancer; 2012 Oct 01; 118(19):4737-47. PubMed ID: 22415526
    [Abstract] [Full Text] [Related]

  • 25. Total Laparoscopic Radical Resection of S1 + S4 for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma (With Video).
    Huang J, Li JW, Xu D.
    Ann Surg Oncol; 2024 Sep 01; 31(9):5631-5635. PubMed ID: 38833055
    [Abstract] [Full Text] [Related]

  • 26. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma.
    Bird N, McKenna A, Dunne D, Francis B, Fenwick S, Poston G, Jones R, Malik H.
    Eur J Surg Oncol; 2019 Feb 01; 45(2):192-197. PubMed ID: 30297275
    [Abstract] [Full Text] [Related]

  • 27. One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study.
    Tan JW, Hu BS, Chu YJ, Tan YC, Ji X, Chen K, Ding XM, Zhang A, Chen F, Dong JH.
    World J Surg; 2013 Mar 01; 37(3):614-21. PubMed ID: 23283218
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH, Jia YB, Song QX, Wang JB, Wang NN, Cheng YF.
    Asian Pac J Cancer Prev; 2015 Mar 01; 16(6):2245-50. PubMed ID: 25824745
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.
    Vasilieva L, Papadhimitriou SI, Alexopoulou A, Kostopoulos I, Papiris K, Pavlidis D, Xinopoulos D, Romanos A, Dourakis SP.
    Arab J Gastroenterol; 2016 Dec 01; 17(4):181-184. PubMed ID: 27914884
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The "Hand as Foot" teaching method in Bismuth-Corlette classification of hilar cholangiocarcinoma.
    Fan S, Yang L, Cao X, Zhang X.
    Asian J Surg; 2022 Jul 01; 45(7):1459-1460. PubMed ID: 35288006
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY.
    World J Gastroenterol; 2016 Feb 28; 22(8):2601-10. PubMed ID: 26937148
    [Abstract] [Full Text] [Related]

  • 38. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
    Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH.
    Ann Surg; 2001 Oct 28; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
    [Abstract] [Full Text] [Related]

  • 39. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma.
    Ye XW, Hu HJ, Xiong XZ, Lu J, Cheng NS.
    Surg Today; 2021 Aug 28; 51(8):1352-1360. PubMed ID: 33651221
    [Abstract] [Full Text] [Related]

  • 40. Preoperative monocyte-to-lymphocyte ratio as a prognosis predictor after curative hepatectomy for intrahepatic cholangiocarcinoma.
    Tao BF, Zhu HQ, Qi LN, Zhong JH, Mai RY, Ma L.
    BMC Cancer; 2024 Sep 27; 24(1):1179. PubMed ID: 39333901
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.